Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis.
about
Melioidosis: epidemiology, pathophysiology, and management.Outcomes of patients with melioidosis treated with meropenemIncreasing incidence of human melioidosis in Northeast ThailandStrategies to Reduce Mortality from Bacterial Sepsis in Adults in Developing CountriesManagement of melioidosisThe epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective studyPresent and future therapeutic strategies for melioidosis and glanders.Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infectionDelineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophagesPolysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophilsTreatment and prophylaxis of melioidosisGlutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria.Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione.Whole-Genome Sequences of Burkholderia pseudomallei Isolates Exhibiting Decreased Meropenem Susceptibility.Melioidosis and the kidney.Epidemiology of community-acquired and nosocomial bloodstream infections in tropical Australia: a 12-month prospective study.Burkholderia pseudomallei stimulates low interleukin-8 production in the human lung epithelial cell line A549.Nitric oxide-dependent killing of aerobic, anaerobic and persistent Burkholderia pseudomallei.Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock.Case Report: Fatal Pediatric Melioidosis Despite Optimal Intensive Care.Melioidosis: An Australian Perspective
P2860
Q24522461-D7037009-8194-4B6D-B435-8592362DBA74Q24567571-C5362F72-41CE-400F-859A-247DB2C298E7Q24605111-0474F228-A805-4852-A859-9EE4A66A547EQ27486641-1B8FDA1D-B24E-4E74-A609-D96358E900BFQ28245689-F92E12C3-D11D-4B02-8070-8669CF5B24CBQ33769912-071A68BF-49D0-4A02-A850-C48393ABDC65Q33797791-D76F2F07-3621-4BF9-A3E0-2C7EAE9FC4E6Q33826261-711FB3DE-D6F5-421B-9B35-E1CD69128461Q34075114-5B7B14DA-A237-48CB-AF5A-AB701A066D39Q34243707-B4139FE5-3A3F-4F56-A86C-EB448A487A64Q34517713-173777B3-F1E5-43A2-AFD8-AEDF65BA794AQ34538191-8CCCFCF4-FE9F-43D6-8BF2-B9E51B889F6FQ36005335-2834A4D5-F7ED-4789-8B80-3BE7629509B0Q37319232-42083785-A335-425E-A90C-15AF238B4BADQ37740865-F43B435D-409A-4980-BECB-EC91B889C2BDQ38070912-3C3A71B6-B7B3-4F4F-AFAA-DC17F905CD07Q38977160-52367D59-DB59-4481-BA2A-2F779CFD0EF1Q40514899-09AD0360-551B-47E7-A9F3-8C727B448E41Q42198497-BE3BB69D-7B31-48A6-B553-941DA99ED8C9Q44803821-3D22C79E-0C25-49E3-AC77-CC2733D5C35DQ50088444-FBEB90DA-C6BB-4502-A3B0-2B8CF42ED314Q57147824-0BC87104-10AE-419B-8A6A-2AF022B42523
P2860
Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Adjunctive granulocyte colony- ...... ptic shock due to melioidosis.
@en
Adjunctive granulocyte colony- ...... ptic shock due to melioidosis.
@nl
type
label
Adjunctive granulocyte colony- ...... ptic shock due to melioidosis.
@en
Adjunctive granulocyte colony- ...... ptic shock due to melioidosis.
@nl
prefLabel
Adjunctive granulocyte colony- ...... ptic shock due to melioidosis.
@en
Adjunctive granulocyte colony- ...... ptic shock due to melioidosis.
@nl
P2860
P50
P356
P1476
Adjunctive granulocyte colony- ...... ptic shock due to melioidosis.
@en
P2093
Dianne P Stephens
P2860
P356
10.1086/380456
P407
P577
2003-12-04T00:00:00Z